30
Participants
Start Date
December 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Veregen
Patients in treatment arm 1 will apply Veregen® 15% ointment (approved commercial source in US) in a total of 750 mg/day for one week, corresponding to application of maximal about 106,9 mg catechins/d, thereof maximal 81 mg ECGg per day). Patients will be instructed to apply fix portions of 250 mg three times daily on the defined anogenital administration area.
Green Tea
"Healthy volunteers in treatment arm 2 will drink Lipton® Green Limone in a total of 1500 mL/d for one week, in portions of 500 mL three times daily after the meals"
CardioSec Clinical Reasearch GmbH, Erfurt
Lead Sponsor
MediGene
INDUSTRY